Global Pneumoconiosis Market Research Report 2023

Pneumoconiosis is an occupational lung disease and a restrictive lung disease caused by the inhalation of dust, often in mines and from agriculture.

The global Pneumoconiosis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In 2013 pneumoconiosis resulted in 260,000 deaths up from 251,000 deaths in 1990. Of these deaths 46,000 were due to silicosis, 24,000 due to asbestosis and 25,000 due to coal workers pneumoconiosis.

This report aims to provide a comprehensive presentation of the global market for Pneumoconiosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumoconiosis.

The Pneumoconiosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pneumoconiosis market comprehensively. Regional market sizes, concerning products by cause, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumoconiosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by cause, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Cause

1.2.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2018 VS 2022 VS 2029

1.2.2 Organic Dusts

1.2.3 Non-Organic Substances

1.3 Market by Application

1.3.1 Global Pneumoconiosis Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pneumoconiosis Market Perspective (2018-2029)

2.2 Pneumoconiosis Growth Trends by Region

2.2.1 Global Pneumoconiosis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pneumoconiosis Historic Market Size by Region (2018-2023)

2.2.3 Pneumoconiosis Forecasted Market Size by Region (2024-2029)

2.3 Pneumoconiosis Market Dynamics

2.3.1 Pneumoconiosis Industry Trends

2.3.2 Pneumoconiosis Market Drivers

2.3.3 Pneumoconiosis Market Challenges

2.3.4 Pneumoconiosis Market Restraints

3.1 Global Top Pneumoconiosis Players by Revenue

3.1.1 Global Top Pneumoconiosis Players by Revenue (2018-2023)

3.1.2 Global Pneumoconiosis Revenue Market Share by Players (2018-2023)

3.2 Global Pneumoconiosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pneumoconiosis Revenue

3.4 Global Pneumoconiosis Market Concentration Ratio

3.4.1 Global Pneumoconiosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pneumoconiosis Revenue in 2022

3.5 Pneumoconiosis Key Players Head office and Area Served

3.6 Key Players Pneumoconiosis Product Solution and Service

3.7 Date of Enter into Pneumoconiosis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pneumoconiosis Historic Market Size by Cause (2018-2023)

4.2 Global Pneumoconiosis Forecasted Market Size by Cause (2024-2029)

5.1 Global Pneumoconiosis Historic Market Size by Application (2018-2023)

5.2 Global Pneumoconiosis Forecasted Market Size by Application (2024-2029)

6.1 North America Pneumoconiosis Market Size (2018-2029)

6.2 North America Pneumoconiosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pneumoconiosis Market Size by Country (2018-2023)

6.4 North America Pneumoconiosis Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pneumoconiosis Market Size (2018-2029)

7.2 Europe Pneumoconiosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pneumoconiosis Market Size by Country (2018-2023)

7.4 Europe Pneumoconiosis Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pneumoconiosis Market Size (2018-2029)

8.2 Asia-Pacific Pneumoconiosis Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pneumoconiosis Market Size by Region (2018-2023)

8.4 Asia-Pacific Pneumoconiosis Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pneumoconiosis Market Size (2018-2029)

9.2 Latin America Pneumoconiosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pneumoconiosis Market Size by Country (2018-2023)

9.4 Latin America Pneumoconiosis Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pneumoconiosis Market Size (2018-2029)

10.2 Middle East & Africa Pneumoconiosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pneumoconiosis Market Size by Country (2018-2023)

10.4 Middle East & Africa Pneumoconiosis Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Pneumoconiosis Introduction

11.1.4 Novartis Revenue in Pneumoconiosis Business (2018-2023)

11.1.5 Novartis Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Pneumoconiosis Introduction

11.2.4 Abbott Revenue in Pneumoconiosis Business (2018-2023)

11.2.5 Abbott Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Detail

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Pneumoconiosis Introduction

11.3.4 Eli Lilly Revenue in Pneumoconiosis Business (2018-2023)

11.3.5 Eli Lilly Recent Development

11.4 Sunpharma

11.4.1 Sunpharma Company Detail

11.4.2 Sunpharma Business Overview

11.4.3 Sunpharma Pneumoconiosis Introduction

11.4.4 Sunpharma Revenue in Pneumoconiosis Business (2018-2023)

11.4.5 Sunpharma Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Pneumoconiosis Introduction

11.5.4 Sanofi Revenue in Pneumoconiosis Business (2018-2023)

11.5.5 Sanofi Recent Development

11.6 Novo Nordisk

11.6.1 Novo Nordisk Company Detail

11.6.2 Novo Nordisk Business Overview

11.6.3 Novo Nordisk Pneumoconiosis Introduction

11.6.4 Novo Nordisk Revenue in Pneumoconiosis Business (2018-2023)

11.6.5 Novo Nordisk Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Detail

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca Pneumoconiosis Introduction

11.7.4 AstraZeneca Revenue in Pneumoconiosis Business (2018-2023)

11.7.5 AstraZeneca Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pneumoconiosis Market Size Growth Rate by Cause (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Organic Dusts

    Table 3. Key Players of Non-Organic Substances

    Table 4. Global Pneumoconiosis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Pneumoconiosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Pneumoconiosis Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Pneumoconiosis Market Share by Region (2018-2023)

    Table 8. Global Pneumoconiosis Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Pneumoconiosis Market Share by Region (2024-2029)

    Table 10. Pneumoconiosis Market Trends

    Table 11. Pneumoconiosis Market Drivers

    Table 12. Pneumoconiosis Market Challenges

    Table 13. Pneumoconiosis Market Restraints

    Table 14. Global Pneumoconiosis Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Pneumoconiosis Market Share by Players (2018-2023)

    Table 16. Global Top Pneumoconiosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumoconiosis as of 2022)

    Table 17. Ranking of Global Top Pneumoconiosis Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Pneumoconiosis Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Pneumoconiosis Product Solution and Service

    Table 21. Date of Enter into Pneumoconiosis Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Pneumoconiosis Market Size by Cause (2018-2023) & (US$ Million)

    Table 24. Global Pneumoconiosis Revenue Market Share by Cause (2018-2023)

    Table 25. Global Pneumoconiosis Forecasted Market Size by Cause (2024-2029) & (US$ Million)

    Table 26. Global Pneumoconiosis Revenue Market Share by Cause (2024-2029)

    Table 27. Global Pneumoconiosis Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Pneumoconiosis Revenue Market Share by Application (2018-2023)

    Table 29. Global Pneumoconiosis Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Pneumoconiosis Revenue Market Share by Application (2024-2029)

    Table 31. North America Pneumoconiosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Pneumoconiosis Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Pneumoconiosis Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Pneumoconiosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Pneumoconiosis Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Pneumoconiosis Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Pneumoconiosis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Pneumoconiosis Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Pneumoconiosis Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Pneumoconiosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Pneumoconiosis Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Pneumoconiosis Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Pneumoconiosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Pneumoconiosis Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Pneumoconiosis Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Novartis Company Detail

    Table 47. Novartis Business Overview

    Table 48. Novartis Pneumoconiosis Product

    Table 49. Novartis Revenue in Pneumoconiosis Business (2018-2023) & (US$ Million)

    Table 50. Novartis Recent Development

    Table 51. Abbott Company Detail

    Table 52. Abbott Business Overview

    Table 53. Abbott Pneumoconiosis Product

    Table 54. Abbott Revenue in Pneumoconiosis Business (2018-2023) & (US$ Million)

    Table 55. Abbott Recent Development

    Table 56. Eli Lilly Company Detail

    Table 57. Eli Lilly Business Overview

    Table 58. Eli Lilly Pneumoconiosis Product

    Table 59. Eli Lilly Revenue in Pneumoconiosis Business (2018-2023) & (US$ Million)

    Table 60. Eli Lilly Recent Development

    Table 61. Sunpharma Company Detail

    Table 62. Sunpharma Business Overview

    Table 63. Sunpharma Pneumoconiosis Product

    Table 64. Sunpharma Revenue in Pneumoconiosis Business (2018-2023) & (US$ Million)

    Table 65. Sunpharma Recent Development

    Table 66. Sanofi Company Detail

    Table 67. Sanofi Business Overview

    Table 68. Sanofi Pneumoconiosis Product

    Table 69. Sanofi Revenue in Pneumoconiosis Business (2018-2023) & (US$ Million)

    Table 70. Sanofi Recent Development

    Table 71. Novo Nordisk Company Detail

    Table 72. Novo Nordisk Business Overview

    Table 73. Novo Nordisk Pneumoconiosis Product

    Table 74. Novo Nordisk Revenue in Pneumoconiosis Business (2018-2023) & (US$ Million)

    Table 75. Novo Nordisk Recent Development

    Table 76. AstraZeneca Company Detail

    Table 77. AstraZeneca Business Overview

    Table 78. AstraZeneca Pneumoconiosis Product

    Table 79. AstraZeneca Revenue in Pneumoconiosis Business (2018-2023) & (US$ Million)

    Table 80. AstraZeneca Recent Development

    Table 81. Research Programs/Design for This Report

    Table 82. Key Data Information from Secondary Sources

    Table 83. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pneumoconiosis Market Size Comparison by Cause (2023-2029) & (US$ Million)

    Figure 2. Global Pneumoconiosis Market Share by Cause: 2022 VS 2029

    Figure 3. Organic Dusts Features

    Figure 4. Non-Organic Substances Features

    Figure 5. Global Pneumoconiosis Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Pneumoconiosis Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals Case Studies

    Figure 8. Clinics Case Studies

    Figure 9. Others Case Studies

    Figure 10. Pneumoconiosis Report Years Considered

    Figure 11. Global Pneumoconiosis Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Pneumoconiosis Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Pneumoconiosis Market Share by Region: 2022 VS 2029

    Figure 14. Global Pneumoconiosis Market Share by Players in 2022

    Figure 15. Global Top Pneumoconiosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumoconiosis as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Pneumoconiosis Revenue in 2022

    Figure 17. North America Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Pneumoconiosis Market Share by Country (2018-2029)

    Figure 19. United States Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Pneumoconiosis Market Share by Country (2018-2029)

    Figure 23. Germany Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Pneumoconiosis Market Share by Region (2018-2029)

    Figure 31. China Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Pneumoconiosis Market Share by Country (2018-2029)

    Figure 39. Mexico Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Pneumoconiosis Market Share by Country (2018-2029)

    Figure 43. Turkey Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Pneumoconiosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Novartis Revenue Growth Rate in Pneumoconiosis Business (2018-2023)

    Figure 46. Abbott Revenue Growth Rate in Pneumoconiosis Business (2018-2023)

    Figure 47. Eli Lilly Revenue Growth Rate in Pneumoconiosis Business (2018-2023)

    Figure 48. Sunpharma Revenue Growth Rate in Pneumoconiosis Business (2018-2023)

    Figure 49. Sanofi Revenue Growth Rate in Pneumoconiosis Business (2018-2023)

    Figure 50. Novo Nordisk Revenue Growth Rate in Pneumoconiosis Business (2018-2023)

    Figure 51. AstraZeneca Revenue Growth Rate in Pneumoconiosis Business (2018-2023)

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed